IHH Annual Report 2024

69 Work Experience Mr Jean-François Naa was appointed the Chief Executive Officer (CEO) of IHH Healthcare Malaysia on 1 March 2020. He provides the strategic direction and maintains high standards of operational and clinical excellence for IHH’s integrated healthcare businesses in Malaysia, which includes a network of 18 hospitals encompassing Gleneagles Hospitals, Island Hospital, Pantai Hospitals, Prince Court Medical Centre and Timberland Medical Centre, as well as ancillary services such as Premier Integrated Labs and Premier Integrated Rehab. Mr Jean-François has more than 30 years of experience in the healthcare industry and has held the role of Chief Executive Officer of several IHH Healthcare entities since 2012. He has been the Chief Executive Officer of Gleneagles Hospital Johor and Gleneagles Hospital Kota Kinabalu in Malaysia, Regional Chief Executive Officer of South and East Malaysia and interim Chief Executive Officer of IHH Healthcare India. In Singapore, he was the covering Chief Executive Officer for Gleneagles Hospital Singapore, Deputy Chief Executive Officer for Mount Elizabeth Novena Hospital as well as Chief Executive Officer of Gleneagles Clinical Research Centre. Mr Jean-François spent the early part of his career in sales and marketing for the pharmaceutical industry in Europe. He joined Novartis Thailand in 2002 as the Oncology Medical Advisor/Clinical Research Manager before being appointed as Head, Global Patient Access, Asia-Pacific for Novartis Oncology. In 2006, he became the General Manager of Novartis Pharmaceuticals to oversee the business in Vietnam and Cambodia. In 2009, Jean-François took on the role of Vice President of Primary Care at Astra Zeneca in Thailand. Academic/Professional Qualification(s) • Master of Sciences, Engineer in Biochemistry and Biotechnology, HEPL, Liege, Belgium • Genetic engineering specialisation, EU scholarship program, Comett, France • Oncology preceptorship, Baylor College of Medicine, USA Work Experience Dr Peter Chow was appointed as Chief Executive Officer of IHH Singapore on 1 April 2024. He spearheads strategic initiatives and drives operational excellence across IHH’s business units in Singapore, which include the Gleneagles, Mount Elizabeth, Mount Elizabeth Novena, and Parkway East hospitals, Parkway Shenton Pte Ltd, Parkway MediCentre, IXchange, Parkway Radiology, Parkway Cancer Centre and Parkway Rehab etc. Dr Chow joined IHH in 2018 and was appointed as Chief Executive Officer of Mount Elizabeth Novena Hospital in 2020, where he grew the medical facility as a premier flagship hospital both locally and in the region. He was also awarded the Public Service Medal (Covid-19) and Covid-19 Resilience Medal in 2022 and 2023 respectively for his healthcare leadership role during the Covid-19 pandemic and for supporting various national pandemic efforts in Singapore. Trained as a dental surgeon with the National University of Singapore, Dr Chow has over 20 years of healthcare management experience spanning both public and private sectors in Singapore. He started his career as a dental officer and subsequently took on different management roles including quality, training, manpower, as well as managed outpatient clinical services, giving him broad-based experience in healthcare. Prior to IHH, he was with National Healthcare Group (NHG) during which he assumed various roles including Director of Quality & College, Director of Corporate Development & Communications and Chief Operating Officer of NHG Polyclinics. Academic/Professional Qualification(s) • Bachelor of Dental Surgery, National University of Singapore • Master of Health Science (Management), University of Sydney • Executive Program (Managing Health Care Delivery), Harvard Business School Notes • Does not have any family relationships with any directors and/or any major shareholders of the Company • Does not have any conflict of interest with the Company • Does not have any convictions for offences within the past five years other than for traffic offences, if any Dr Peter Chow Chief Executive Officer, IHH Healthcare Singapore Nationality: Singaporean Gender: Male Age: 50 (as of 1 April 2025) Date of Appointment: 1 April 2024 Jean-François Naa Chief Executive Officer, IHH Healthcare Malaysia Nationality: Belgian Gender: Male Age: 58 (as of 1 April 2025) Date of Appointment: 1 March 2020 Country Leadership

RkJQdWJsaXNoZXIy NDgzMzc=